Relay Therapeutics to Announce Q4 and Full Year 2025 Results

The biotech company will report its latest financial performance next week.

Published on Feb. 27, 2026

Got story updates? Submit your updates here. ›

Relay Therapeutics, Inc., a clinical-stage precision medicine company, announced that it will report its fourth quarter and full year 2025 financial results on February 26, 2026. The company develops medicines that target proteins to treat a range of diseases.

Why it matters

As a clinical-stage biotech company, Relay Therapeutics' financial performance and pipeline updates are closely watched by investors and the pharmaceutical industry. The company's ability to advance its drug candidates through clinical trials and towards potential regulatory approval is a key indicator of its future growth prospects.

The details

Relay Therapeutics will host a conference call and webcast on February 26, 2026 at 8:00 a.m. Eastern Time to discuss the financial results and provide a business update. The company's pipeline includes several drug candidates in various stages of clinical development for diseases such as cancer and genetic disorders.

  • Relay Therapeutics will report Q4 and full year 2025 financial results on February 26, 2026.
  • The company will host a conference call and webcast on February 26, 2026 at 8:00 a.m. Eastern Time.

The players

Relay Therapeutics, Inc.

A clinical-stage precision medicine company that develops medicines targeting proteins to treat a range of diseases.

Got photos? Submit your photos here. ›

What’s next

Investors and analysts will be closely watching Relay Therapeutics' financial results and pipeline updates to assess the company's progress and future growth potential.

The takeaway

Relay Therapeutics' upcoming financial report will provide insights into the company's financial health and the advancement of its drug development pipeline, which are key factors in evaluating the biotech's long-term prospects.